Arrowstreet Capital’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-29,162
| Closed | -$1.77M | – | 1300 |
|
|
2022
Q2 | $1.77M | Buy |
+29,162
| New | +$1.77M | ﹤0.01% | 812 |
|
|
2021
Q4 | – | Sell |
-47,100
| Closed | -$5.27M | – | 1484 |
|
|
2021
Q3 | $5.27M | Sell |
47,100
-33,900
| -42% | -$3.79M | 0.01% | 930 |
|
|
2021
Q2 | $13.1M | Buy |
+81,000
| New | +$13.1M | 0.02% | 755 |
|
|
2020
Q4 | – | Sell |
-6,281
| Closed | -$525K | – | 2323 |
|
|
2020
Q3 | $525K | Buy |
+6,281
| New | +$525K | ﹤0.01% | 2002 |
|
|
2020
Q2 | – | Sell |
-260,996
| Closed | -$11.1M | – | 2328 |
|
|
2020
Q1 | $11.1M | Buy |
260,996
+157,196
| +151% | +$6.67M | 0.03% | 451 |
|
|
2019
Q4 | $6.32M | Buy |
+103,800
| New | +$6.32M | 0.01% | 788 |
|